ARTICLE | Clinical News
Lymphoseek tilmanocept regulatory update
August 15, 2011 7:00 AM UTC
Neoprobe submitted an NDA to FDA for Lymphoseek tilmanocept for use in intraoperative lymphatic mapping. Lymphoseek is a Tc99m-labeled radioactive tracing agent. In June, Neoprobe filed a formal respo...